المؤلفون: Gillen Jm

المصدر: Southern Medical Journal. 51:390-393

مصطلحات موضوعية: Insurance, Health, Actuarial science, business.industry, Health insurance, Humans, Medicine, General Medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d6f0ecf30b581033ee1e386a6441804
https://doi.org/10.1097/00007611-195803000-00022

المؤلفون: Gillen JM; The University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, USA., Grimes SC; The University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, USA., Essel KG; The University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, USA., Duininck GE; The University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, USA., Zhao D; The University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, USA., Thompson JS; The University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, USA., Richardson DL; The University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, USA.

المصدر: Gynecologic oncology reports [Gynecol Oncol Rep] 2020 Oct 21; Vol. 34, pp. 100660. Date of Electronic Publication: 2020 Oct 21 (Print Publication: 2020).

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101652231 Publication Model: eCollection Cited Medium: Print ISSN: 2352-5789 (Print) Linking ISSN: 23525789 NLM ISO Abbreviation: Gynecol Oncol Rep Subsets: PubMed not MEDLINE

المؤلفون: Greenwade MM; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. Electronic address: molly-greenwade@ouhsc.edu., Moore KN; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. Electronic address: kathleen-moore@ouhsc.edu., Gillen JM; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. Electronic address: jessica-gillen@ouhsc.edu., Ding K; Department of Biostatistics and Epidemiology, University of Oklahoma HSC, Oklahoma City, OK, United States. Electronic address: kai-ding@ouhsc.edu., Rowland MR; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. Electronic address: michelle-rowland@ouhsc.edu., Crim AK; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. Electronic address: aleia-crim@ouhsc.edu., Kleis B; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. Electronic address: bailey-kleis@ouhsc.edu., Gunderson CC; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. Electronic address: camille-gunderson@ouhsc.edu.

المصدر: Gynecologic oncology [Gynecol Oncol] 2017 Sep; Vol. 146 (3), pp. 465-469. Date of Electronic Publication: 2017 Jul 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Clinical Trials as Topic* , Patient Participation* , Patient Selection*, Neoplasms, Glandular and Epithelial/*therapy , Ovarian Neoplasms/*therapy, Adult ; Age Factors ; Aged ; Aged, 80 and over ; Antineoplastic Agents/administration & dosage ; Carcinoma, Ovarian Epithelial ; Chemotherapy, Adjuvant ; Cytoreduction Surgical Procedures ; Disease-Free Survival ; Female ; Humans ; Middle Aged ; Neoadjuvant Therapy ; Neoplasms, Glandular and Epithelial/pathology ; Ovarian Neoplasms/pathology ; Retrospective Studies ; Survival Rate